75 related articles for article (PubMed ID: 1393774)
1. A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover.
Horwitz MJ; Tedesco MB; Sereika SM; Prebehala L; Gundberg CM; Hollis BW; Bisello A; Garcia-Ocaña A; Carneiro RM; Stewart AF
J Bone Miner Res; 2011 Sep; 26(9):2287-97. PubMed ID: 21544866
[TBL] [Abstract][Full Text] [Related]
2. Optimal dosing and delivery of parathyroid hormone and its analogues for osteoporosis and hypoparathyroidism - translating the pharmacology.
Tay D; Cremers S; Bilezikian JP
Br J Clin Pharmacol; 2018 Feb; 84(2):252-267. PubMed ID: 29049872
[TBL] [Abstract][Full Text] [Related]
3. Skeletal recovery after weaning does not require PTHrP.
Kirby BJ; Ardeshirpour L; Woodrow JP; Wysolmerski JJ; Sims NA; Karaplis AC; Kovacs CS
J Bone Miner Res; 2011 Jun; 26(6):1242-51. PubMed ID: 21308774
[TBL] [Abstract][Full Text] [Related]
4. Osteostatin, a peptide for the future treatment of musculoskeletal diseases.
Lozano D; Gortazar AR; Portal-Núñez S
Biochem Pharmacol; 2024 May; 223():116177. PubMed ID: 38552853
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic Regulation of Parathyroid Hormone-Related Protein: Functional Implications for Skeletal Malignancy.
Frieling JS; Lynch CC
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31181800
[TBL] [Abstract][Full Text] [Related]
6. Fracture healing physiology and the quest for therapies for delayed healing and nonunion.
Kostenuik P; Mirza FM
J Orthop Res; 2017 Feb; 35(2):213-223. PubMed ID: 27743449
[TBL] [Abstract][Full Text] [Related]
7. Recent advances toward the clinical application of PTH (1-34) in fracture healing.
Cipriano CA; Issack PS; Shindle L; Werner CM; Helfet DL; Lane JM
HSS J; 2009 Sep; 5(2):149-53. PubMed ID: 19290582
[TBL] [Abstract][Full Text] [Related]
8. Expression of parathyroid hormone-related peptide (PthrP) and its receptor (PTH1R) during the histogenesis of cartilage and bone in the chicken mandibular process.
Zhao Q; Brauer PR; Xiao L; McGuire MH; Yee JA
J Anat; 2002 Aug; 201(2):137-51. PubMed ID: 12220122
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone in the treatment of involutional osteoporosis: back to the future.
Reginster JY; Taquet AN; Fraikin G; Gosset C; Zegels B
Osteoporos Int; 1997; 7 Suppl 3():S163-8. PubMed ID: 9536325
[No Abstract] [Full Text] [Related]
10. Effects of continuous glucocorticoid infusion on bone metabolism in the rat.
King CS; Weir EC; Gundberg CW; Fox J; Insogna KL
Calcif Tissue Int; 1996 Sep; 59(3):184-91. PubMed ID: 8694896
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone (PTH)-related protein(1-36) is equipotent to PTH(1-34) in humans.
Everhart-Caye M; Inzucchi SE; Guinness-Henry J; Mitnick MA; Stewart AF
J Clin Endocrinol Metab; 1996 Jan; 81(1):199-208. PubMed ID: 8550752
[TBL] [Abstract][Full Text] [Related]
12. [Development of hPTHrP (1-36) as an anabolic therapeutic agent for osteoporosis].
Takeuchi Y
Clin Calcium; 2011 Jan; 21(1):28-32. PubMed ID: 21187591
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone and parathyroid hormone-related protein analogs as therapies for osteoporosis.
Augustine M; Horwitz MJ
Curr Osteoporos Rep; 2013 Dec; 11(4):400-6. PubMed ID: 24078470
[TBL] [Abstract][Full Text] [Related]
14. Synthetic parathyroid hormone-like protein (1-74) is anabolic for bone in vivo.
Weir EC; Terwilliger G; Sartori L; Insogna KL
Calcif Tissue Int; 1992 Jul; 51(1):30-4. PubMed ID: 1393774
[TBL] [Abstract][Full Text] [Related]
15. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34 on bone in rats.
Hock JM; Fonseca J; Gunness-Hey M; Kemp BE; Martin TJ
Endocrinology; 1989 Oct; 125(4):2022-7. PubMed ID: 2791976
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
